| A 12-month phase 3 study of pasireotide in Cushing's disease A Colao, S Petersenn, J Newell-Price, JW Findling, F Gu, M Maldonado, ... New England Journal of Medicine 366 (10), 914-924, 2012 | 697 | 2012 |
| Challenges in the diagnosis and management of acromegaly: a focus on comorbidities A Abreu, AP Tovar, R Castellanos, A Valenzuela, CMG Giraldo, ... Pituitary 19, 448-457, 2016 | 180 | 2016 |
| High variability in baseline urinary free cortisol values in patients with Cushing's disease S Petersenn, J Newell‐Price, JW Findling, F Gu, M Maldonado, K Sen, ... Clinical Endocrinology 80 (2), 261-269, 2014 | 134 | 2014 |
| Controversial issues in the management of hyperprolactinemia and prolactinomas–An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and … L Vilar, J Abucham, JL Albuquerque, LA Araujo, MF Azevedo, ... Archives of endocrinology and metabolism 62, 236-263, 2018 | 128 | 2018 |
| Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study R Pivonello, S Petersenn, J Newell‐Price, JW Findling, F Gu, ... Clinical Endocrinology 81 (3), 408-417, 2014 | 119 | 2014 |
| Treatment of acromegaly with octreotide‐LAR: extensive experience in a Brazilian institution RS Jallad, NRC Musolino, LR Salgado, MD Bronstein Clinical endocrinology 63 (2), 168-175, 2005 | 109 | 2005 |
| Management of pituitary tumors in pregnancy MD Bronstein, DB Paraiba, RS Jallad Nature Reviews Endocrinology 7 (5), 301-310, 2011 | 101 | 2011 |
| Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment APM Casarini, RS Jallad, EM Pinto, IC Soares, S Nonogaki, ... Pituitary 12, 297-303, 2009 | 91 | 2009 |
| Does partial surgical tumour removal influence the response to octreotide‐LAR in acromegalic patients previously resistant to the somatostatin analogue? RS Jallad, NR Musolino, S Kodaira, VA Cescato, MD Bronstein Clinical endocrinology 67 (2), 310-315, 2007 | 82 | 2007 |
| Treatment of acromegaly: is there still a place for radiotherapy? RS Jallad, NR Musolino, LR Salgado, MD Bronstein Pituitary 10, 53-59, 2007 | 73 | 2007 |
| Optimizing medical therapy of acromegaly: beneficial effects of cabergoline in patients uncontrolled with long-acting release octreotide RS Jallad, MD Bronstein Neuroendocrinology 90 (1), 82-92, 2009 | 68 | 2009 |
| Pharmacokinetic profile of lanreotide Autogel® in patients with acromegaly after four deep subcutaneous injections of 60, 90 or 120 mg every 28 days M Bronstein, N Musolino, R Jallad, JM Cendros, J Ramis, R Obach, ... Clinical endocrinology 63 (5), 514-519, 2005 | 67 | 2005 |
| Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: preferential expression of somatostatin receptor … APM Casarini, EM Pinto, RS Jallad, RR Giorgi, D Giannella-Neto, ... Journal of Endocrinological Investigation 29, 826-830, 2006 | 62 | 2006 |
| Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing’s disease: results from an open-ended, open-label extension … J Schopohl, F Gu, R Rubens, L Van Gaal, J Bertherat, M Ligueros-Saylan, ... Pituitary 18, 604-612, 2015 | 54 | 2015 |
| Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors I Shimon, RS Jallad, M Fleseriu, CG Yedinak, Y Greenman, MD Bronstein European journal of endocrinology 172 (6), 707-713, 2015 | 45 | 2015 |
| Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil L Vieira Neto, J Abucham, LA Araujo, CL Boguszewski, MD BRONSTEIN, ... Arquivos Brasileiros de Endocrinologia e Metabologia, 2011 | 40 | 2011 |
| Clomiphene citrate for treatment of acromegaly not controlled by conventional therapies FH Duarte, RS Jallad, MD Bronstein The Journal of Clinical Endocrinology & Metabolism 100 (5), 1863-1869, 2015 | 38 | 2015 |
| Machine learning-based prediction model for treatment of acromegaly with first-generation somatostatin receptor ligands LE Wildemberg, AH da Silva Camacho, RL Miranda, PCL Elias, ... The Journal of Clinical Endocrinology & Metabolism 106 (7), 2047-2056, 2021 | 37 | 2021 |
| Outcome of pregnancies in a large cohort of women with acromegaly RS Jallad, I Shimon, M Fraenkel, V Medvedovsky, A Akirov, FH Duarte, ... Clinical endocrinology 88 (6), 896-907, 2018 | 35 | 2018 |
| Effects of growth hormone replacement therapy on metabolic and cardiac parameters, in adult patients with childhood-onset growth hormone deficiency RS Jallad, B Liberman, CB Vianna, MLC Vieira, JAF Ramires, ... Growth hormone & IGF research 13 (2-3), 81-88, 2003 | 34 | 2003 |
Marcello D. BronsteinChefe da unidade de Neuroendocrinologia da disciplina de endocrinologia e metabologia do hospital das clinicas da FMUSPVerified email at usp.br
